Challenges and Roadmap to Success in Medical Institution M&A

📖 Approx. 8 minutesPublished: 2026.05.05 ／ Updated 2026.05.08

Current Status and Challenges of Medical Institution M&A

In recent years, M&A (Mergers and Acquisitions) in the healthcare industry has become more than just a means of business expansion; it is increasingly important as a crucial option for resolving pressing issues such as the lack of successors and the maintenance of regional healthcare. In particular, business succession problems faced by small and medium-sized clinics and medical corporations are becoming more serious, and M&A is expected as a solution. However, M&A of medical institutions, unlike general corporate acquisitions, requires clearing specific issues such as the medical fee system, licensing, and the medical corporation system. Furthermore, as it is a business directly related to patients’ lives and health, it is extremely important to achieve a smooth handover while minimizing the impact on employees and patients.

The primary factor behind the increase in medical institution M&A is the aging of physicians and the shortage of successors. Cases where clinic directors, who are often sole proprietors, age and cannot find successors are endless. Additionally, with the promotion of regional healthcare plans and the reorganization of healthcare provision systems in regions, an increasing number of medical corporations are choosing M&A to improve management efficiency, strengthen specialization, and consolidate management resources. However, while considering these backgrounds, specialized knowledge and careful planning are indispensable for successful M&A.

Specifics of M&A in Medical Corporations

Due to the unique nature of their business, M&A of medical institutions involves many considerations different from general corporate M&A. Firstly, there are types of medical corporations such as social medical corporations, foundation medical corporations, and for-profit medical corporations (eiryo-gata), each differing in the presence of equity stakes, the composition of members (shareholders), and decision-making processes. In particular, for non-profit social medical corporations, equity stakes are generally non-transferable, so M&A is typically conducted through business transfers, liquidation of funds in lieu of equity, or changes in officers (chairperson, directors). The liquidation of these funds and changes in membership often involve complex procedures requiring approval from the articles of incorporation and the competent authorities, demanding specialized knowledge.

Furthermore, medical fee schedules are subject to regular revisions, and facility standards and additional benefit requirements are constantly changing. In M&A, it is necessary to thoroughly evaluate whether the target medical institution complies with these systems and whether its profitability can be maintained in the future (due diligence). Additionally, the transfer of various licenses held by medical institutions (e.g., designation as an insured medical institution, certifications for specialized fields) is also a critical issue. Many of these licenses are granted based on individual medical institutions or physician qualifications, and it must be confirmed in advance whether they can be transferred as-is after M&A or if reapplication is necessary. The treatment of business tax is also a point to note; while medical corporations are generally exempt from business tax, M&A schemes may result in taxation in some cases.

Issue	General Corporate M&A	Medical Institution M&A
Type of Medical Corporation	Stock companies, LLCs, etc.	Social medical corporations, foundation medical corporations, for-profit medical corporations, etc.
Equity Stake	Transferable	Generally non-transferable (handled by fund liquidation, etc.)
Licenses	Transferred through business transfer, etc.	Often requires individual reapplication/confirmation
Medical Fees	Limited direct impact	Core of business revenue; significant impact from system changes
Business Tax	Taxable	Generally tax-exempt, but taxation possible depending on the scheme

Due Diligence for Successful M&A

In M&A of medical institutions, due diligence (DD) is one of the most critical processes that determines the success or failure of the transaction. DD refers to the detailed investigation and evaluation of all aspects of the target medical institution, including its finances, legal matters, taxes, and actual medical practices. For medical institutions, it is necessary to evaluate not only the profit on financial statements but also the appropriateness of medical fee claims, compliance with facility standards, history of medical litigation, medical record management status, employee working conditions, and even intangible assets and liabilities such as regional reputation and patient trust.

Particular attention should be paid to fraudulent claims for medical fees and potential risks related to past medical malpractice. If such issues are discovered, substantial claims for repayment or damages may arise after the acquisition. Furthermore, employment contracts and working conditions for medical professionals such as doctors and nurses, as well as the status of provisions for retirement benefits, are essential for accurately assessing post-acquisition labor costs. In M&A of medical institutions, in addition to financial and legal DD, a process called medical DD, where specialists evaluate the quality of medical practice, safety management systems, and compliance status, is crucial. Thoroughly conducting this DD can reduce the risk of unexpected problems arising after the acquisition and enable the calculation of an appropriate acquisition price.

Smooth Handover and Consideration for Stakeholders

During the M&A process, consideration for stakeholders such as employees and patients is extremely important for ensuring business continuity. Especially in medical institutions, long-standing trust relationships rooted in the community and personal connections with patients often form the core of the business. Handover processes that damage these relationships can not only hinder the success of the M&A but also devalue the business itself.

It is essential to explain the intentions of the M&A, future employment conditions, and benefits to employees as early and as carefully as possible. For employees who feel anxious, efforts must be made to resolve their questions and concerns through individual meetings. For patients, sufficient information and careful explanations are necessary regarding the continuity of medical care, whether their primary physician will change, and how to receive future treatment. In some cases, it may be beneficial to have the previous physician continue to provide care for a certain period after the M&A. Maintaining transparency and sincerity throughout the M&A process and striving for communication that considers the perspective of each stakeholder will lead to a smooth handover and business stabilization.

Taxation in M&A and Capital Gains Tax

In M&A of medical institutions, tax treatment is also an important consideration. Particularly for the seller, capital gains tax on the proceeds from the M&A can be a significant burden. When a medical corporation transfers its business, the proceeds are taxed as the corporation’s income. Similarly, for individual clinics, it is taxed as capital gains from the transfer of business assets. The tax rate for capital gains varies depending on factors such as the holding period, but generally, more favorable rates may apply compared to other types of income.

On the buyer’s side, the depreciation of acquired assets, carryforward of net operating losses, and treatment of consumption tax will be affected by the M&A scheme. For example, when acquiring shares of a for-profit medical corporation, the acquisition cost of the shares is calculated considering future dividends. Furthermore, the tax effects also differ depending on the payment method for the M&A consideration (lump sum or installments, cash or stock, etc.). To accurately grasp these tax risks and benefits and select the most advantageous scheme, advice from specialists such as tax accountants and CPAs familiar with M&A is indispensable. Regarding capital gains tax, especially when dissolving a medical corporation, the process involving fund liquidation and distribution of residual assets becomes more complex, requiring intricate tax procedures, thus early consultation with specialists is recommended.

Steps to Successful M&A and Utilization of Experts

To achieve successful M&A of a medical institution, a planned and phased approach is essential. Generally, M&A proceeds in the following steps. First, clarify the purpose of the M&A and consider whether it aligns with your company’s management strategy. Next, gather information on potential sale candidates or set conditions for the medical institutions you wish to acquire. Once potential medical institutions are identified, sign a Memorandum of Understanding (MOU) with the other party, followed by detailed due diligence. Based on the DD results, negotiate the final acquisition price and contract terms, and conclude the M&A agreement. Finally, the M&A is completed through closing procedures such as reporting to the competent authorities, transferring licenses, and explaining to employees and patients.

This series of processes involves many aspects requiring specialized knowledge, making it difficult to proceed solely on your own. In particular, areas unique to medical institutions, such as the medical corporation system, medical fee system, licensing, fund liquidation, and changes in membership, are difficult for non-specialists to accurately assess. Therefore, effectively utilizing the support of specialists such as M&A intermediaries, lawyers, tax accountants, and CPAs is key to leading M&A to success. M&A support organizations familiar with the healthcare industry, in particular, understand industry-specific challenges and can support smooth negotiations and procedural progress. Taking advantage of free consultations and finding reliable experts early on is the first step towards successful M&A.

1. 📋

   Objective Setting

   Clarify M&A objectives and strategy

   Sponsored Links

2. 🔍

   Information Gathering & Selection

   Investigate and narrow down candidate deals

3. 📝

   Due Diligence

   Conduct detailed investigation and evaluation

4. 💼

   Contract Signing

   Negotiate terms and finalize agreement

5. ✅

   Closing

   Complete licenses and handover

M&A of medical institutions is complex and requires specialized knowledge, making expert advice indispensable. At M&A Medical, our specialists with extensive knowledge and experience in the healthcare industry provide comprehensive support, from planning to execution of optimal M&A strategies tailored to your situation. Please feel free to consult with us.

---

Consult M&A Medical for Healthcare Succession

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the transfer of clinics and medical corporations struggling with a lack of successors, as well as strategic acquisitions, on a success fee basis.

• Initial consultation and preliminary assessment are free
• No retainer or monthly fees (success fee only)
• Strict confidentiality (proceeds under NDA)
• Services available nationwide in all 47 prefectures and for all medical specialties

Please consult with us early, even if you only want to know the market value, are facing a lack of successors, or are considering joining a group.

Apply for Free Consultation